RXi Pharmaceuticals has appointed Peter Campochiaro to its scientific advisory board.
Campochiaro is a professor of ophthalmology and neuroscience at Johns Hopkins University School of Medicine. He is also a clinician at the Wilmer Eye Institute with expertise in the molecular pathogenesis of ocular neovascularization and vascular leakage.